Arthur Edwards
Chief Administrative Officer at New Haven Pharmaceuticals, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Larry Dillaha | M | 60 |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | - |
Patrick P. Fourteau | M | 77 |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | - |
Nancy C. Motola | M | 71 |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | 11 years |
Harry Penner | M | 78 |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | 16 years |
Daniel Wagner | M | 53 |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | - |
William Sessa | M | - |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | - |
Michael Milligan | M | - |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Hallal | M | 56 | 10 years | |
Kory Wentworth | M | 45 | 9 years | |
David W. Keiser | M | 72 | 16 years | |
John C. King | M | 49 | 9 years | |
Michael V. Greco | M | 53 | 11 years | |
Larry L. Mathis | M | 80 | 10 years | |
Carsten Boess | M | 57 | 1 years | |
Jeroen van Beek | M | - | 10 years | |
Mike Liu | M | 58 | 5 years | |
Jeffrey Fryer | M | 55 | 9 years | |
John Tilton | M | 56 | 10 years | |
Derek Adams | M | 50 | 11 years | |
Stephan Toutain | M | - | 2 years | |
Hyung Bak | M | - | - | |
Pritesh Gandhi | M | - | 2 years | |
Cheryl Nash | F | - | 4 years | |
James Bilotta | M | - | 10 years | |
Jeremy Springhorn | M | 61 | 9 years | |
Heidi Wagner | F | 59 | 9 years | |
Darren Cline | M | 59 | 3 years | |
Claude Nicaise | M | 71 | 6 years | |
Eric Grinstead | M | 66 | 3 years | |
Paul W. Finnegan | M | 63 | 6 years | |
Camille Bedrosian | M | 71 | 10 years | |
Christopher F. Mojcik | M | 64 | 9 years | |
Lars Robert Boesgaard | M | 55 | 3 years | |
Patrice Coissac | M | 75 | 8 years | |
Vikas Sinha | M | 60 | 11 years | |
Glenn R. Melrose | M | 68 | - | |
Ruedi E. Waeger | M | 80 | 5 years | |
Stephen Basso | M | 58 | 8 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 38 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Arthur Edwards
- Personal Network